Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; Scordo, M.; Giralt, S.; Shah, G. |
| Abstract Title: | Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S179 |
| Language: | English |
| ACCESSION: | WOS:001079705400312 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01878-5 |
| Notes: | Meeting Abstract: P-260 -- The pdf misspelled the author: Khayla last name -- Source: Wos |
